Cancer Prevention, Control, & Population Health Program, Georgia Cancer Center, Department of Medicine, Medical College of Georgia, Augusta University, 1410 Laney Walker Boulevard CN-2116, Augusta, GA, 30912, USA.
Georgia Prevention Institute, Augusta University, 1457 Walton Way, Augusta, GA, 30901, USA.
J Cancer Surviv. 2024 Jun;18(3):781-790. doi: 10.1007/s11764-022-01309-6. Epub 2022 Dec 27.
Our study aimed to examine whether receipt of follow-up care plans is associated with greater guideline-concordant CRC screening stratified by breast, prostate, and lung cancer survivors.
We used data from years 2016, 2018, and 2020 of the Behavioral Risk Factor Surveillance System on 3339 eligible treatment-utilizing cancer survivors with complete treatment. We performed descriptive statistics and multivariable logistic regression to examine the mentioned association.
We observed that 83.9% of breast and 88.2% of prostate cancer survivors with follow-care plans received CRC screening (p-value < 0.001). The lowest CRC screening use was observed among lung cancer (70.8%). In multivariable analysis, receipt of follow-up care plans was strongly associated with greater odds of receiving CRC screening in breast (OR, 2.67; 95% CI: 1.71-4.16) and prostate (OR, 3.81; 95% CI: 2.30-6.31) cancer survivors. Regardless of provider type, 84 to 88% reduced likelihood of receipt of CRC screening when they received follow-up care plans among lung cancer survivors. Among those without follow-up care plans, breast (OR, 0.29; 95% CI: 0.09-0.92) and lung (OR, 0.05; 95% CI: 0.01-0.25) cancer survivors who received care from general practices were less likely to receive CRC screening compared to those who received care from non-general practices.
Receipt of follow-up care plans was associated with greater CRC screening use in breast and prostate cancers. Lung cancer survivors demonstrated lower screening use despite receipt of follow-up care plans.
Patient and provider communication regarding CRC screening recommendation should be included in their follow-up care plans.
本研究旨在探讨接受随访护理计划是否与乳腺癌、前列腺癌和肺癌幸存者的 CRC 筛查更符合指南。
我们使用了 2016 年、2018 年和 2020 年行为风险因素监测系统中 3339 名符合条件的接受治疗的癌症幸存者的完整治疗数据。我们进行了描述性统计和多变量逻辑回归分析，以检查上述关联。
我们发现，83.9%的乳腺癌和 88.2%的前列腺癌幸存者有随访护理计划，接受了 CRC 筛查（p 值<0.001）。肺癌患者的 CRC 筛查使用率最低（70.8%）。在多变量分析中，接受随访护理计划与乳腺癌（OR，2.67；95%CI：1.71-4.16）和前列腺癌（OR，3.81；95%CI：2.30-6.31）幸存者接受 CRC 筛查的几率更高有关。无论提供者类型如何，肺癌幸存者中有 84%至 88%在接受随访护理计划时接受 CRC 筛查的可能性降低。在没有随访护理计划的情况下，与接受非普通实践护理的患者相比，接受普通实践护理的乳腺癌（OR，0.29；95%CI：0.09-0.92）和肺癌（OR，0.05；95%CI：0.01-0.25）幸存者接受 CRC 筛查的可能性较低。
接受随访护理计划与乳腺癌和前列腺癌的 CRC 筛查使用率增加有关。尽管接受了随访护理计划，但肺癌幸存者的筛查使用率仍然较低。
应将 CRC 筛查建议纳入患者和提供者的随访护理计划中。
